Lb Pharmaceuticals earnings were N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest LBRX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$3.6M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LBRX reported annual earnings of -$63.1M, with 905.6% growth. The next LBRX earnings date is Feb 25, 2026.
LBRX earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
LBRX Return on Equity
Insufficient data to display
LBRX Return on Assets
Insufficient data to display
Be the first to know when LBRX announces earnings.
What were Lb Pharmaceuticals's earnings last quarter?
Lb Pharmaceuticals (NASDAQ: LBRX) reported Q3 2025 earnings per share (EPS) of -$0.61, up 98.46% year over year. Total LBRX earnings for the quarter were -$3.56 million. In the same quarter last year, Lb Pharmaceuticals's earnings per share (EPS) was -$39.49.
The next LBRX earnings call is Invalid Date. Add LBRX to your watchlist to be reminded of Lb Pharmaceuticals's next earnings date.
Is Lb Pharmaceuticals profitable or losing money?
As of the last Lb Pharmaceuticals earnings report, Lb Pharmaceuticals is currently losing money. Lb Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was N/A, a N/A decrease year over year.
What was LBRX's earnings growth in the past year?
As of Lb Pharmaceuticals's earnings date in Q1 2026, Lb Pharmaceuticals's earnings has grown year over year. LBRX earnings in the past year totalled N/A.
What are Lb Pharmaceuticals's earnings expectations?
The current EPS estimate for Lb Pharmaceuticals's earnings report in Invalid Date is -$0.58.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.